Mantle cell lymphoma (MCL) is a rare subtype of non-Hodgkin lymphoma (NHL) that originates from B lymphocytes within the mantle zone of lymphoid follicles. MCL…
Malignant neoplasms of the ovary are among the most fatal gynecologic malignancies, and mutations in the BRCA1 and BRCA2 genes significantly increase the risk. Women…
Malignant melanoma is an aggressive form of skin cancer originating from melanocytes. Genetic mutations play a critical role in melanoma progression, with the BRAF V600K…
Malignant melanoma with BRAF V600E mutation is a highly aggressive skin cancer caused by a genetic alteration in the BRAF gene, affecting the MAPK/ERK signaling…
Malignant melanoma with BRAF V600 mutation is an aggressive form of skin cancer characterized by a specific genetic alteration in the BRAF gene, leading to…
Low-grade gliomas (LGGs) are slow-growing primary brain tumors that arise from glial cells. Among the genetic alterations associated with LGGs, the BRAF V600E mutation is…
Low-grade gliomas (LGGs) are slow-growing brain tumors commonly found in children and young adults. A subset of these tumors is associated with BRAF fusion or…
HER2 Negative Advanced Female Breast Cancer is one of the most common subtypes of breast cancer, accounting for approximately 70% of all breast cancer diagnoses.…
Hormone receptor (HR)-positive, HER2-negative advanced breast cancer is a subtype of breast cancer that tests positive for hormone receptors but lacks human epidermal growth factor…
Neuroblastoma, a malignancy originating from neural crest cells, predominantly affects children under five years of age. High-risk neuroblastoma, characterized by specific clinical and biological features,…